Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells

Author:

Ding Siyuan123ORCID,Zhu Shu4,Ren Lili1235,Feng Ningguo123,Song Yanhua1236,Ge Xiaomei37,Li Bin6,Flavell Richard A89ORCID,Greenberg Harry B123ORCID

Affiliation:

1. Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, United States

2. Department of Microbiology and Immunology, Stanford University, Stanford, United States

3. Palo Alto Veterans Institute of Research, VA Palo Alto Health Care System, Palo Alto, United States

4. Institute of Immunology, CAS Key Laboratory of Innate Immunity and Chronic Disease, School of Life Sciences and Medical Center, University of Science and Technology of China, Hefei, China

5. School of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China

6. Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing, China

7. Department of Medicine, Division of Hematology, Stanford University, Stanford, United States

8. Department of Immunobiology, Yale University, New Haven, United States

9. Howard Hughes Medical Institute, Chevy Chase, United States

Abstract

Rotaviruses (RVs), a leading cause of severe diarrhea in young children and many mammalian species, have evolved multiple strategies to counteract the host innate immunity, specifically interferon (IFN) signaling through RV non-structural protein 1 (NSP1). However, whether RV structural components also subvert antiviral response remains under-studied. Here, we found that MAVS, critical for the host RNA sensing pathway upstream of IFN induction, is degraded by the RV RNA methyl- and guanylyl-transferase (VP3) in a host-range-restricted manner. Mechanistically, VP3 localizes to the mitochondria and mediates the phosphorylation of a previously unidentified SPLTSS motif within the MAVS proline-rich region, leading to its proteasomal degradation and blockade of IFN-λ production in RV-infected intestinal epithelial cells. Importantly, VP3 inhibition of MAVS activity contributes to enhanced RV replication and to viral pathogenesis in vivo. Collectively, our findings establish RV VP3 as a viral antagonist of MAVS function in mammals and uncover a novel pathogen-mediated inhibitory mechanism of MAVS signaling.

Funder

Thrasher Research Fund

National Institute of Allergy and Infectious Diseases

Walter V. and Idun Berry Foundation

Institute for Immunity, Transplantation and Infection, Stanford University

National Natural Science Foundation of China

Chinese Academy of Sciences

Howard Hughes Medical Institute

U.S. Department of Veterans Affairs

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3